Neurocrine Biosciences
NBIX
#1202
Rank
NZ$27.57 B
Marketcap
$272.34
Share price
2.21%
Change (1 day)
17.48%
Change (1 year)
Neurocrine Biosciences is an American biopharmaceutical company that develops treatments for neurological and endocrine-related diseases and disorders.

We have found no stock splits for this company